Will Sigma’s ASX 200 debut change investor outlook?

Chemist Warehouse merger remains a key issue for investors as Sigma joins ASX 200 Pharmaceutical wholesaler Sigma Healthcare has been catapulted onto the list of the country’s 200 largest public companies, but analysts are continuing to watch and wait as the Chemist Warehouse (CWH) merger review continues. Sigma’s $2.1bn market capitalisation brought the company inside

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Abatacept shortage hits earlier than forecast
Next ‘Hospitals are death chambers,’ posted former GP